Actively Recruiting
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
Led by Poznan University of Medical Sciences · Updated on 2026-03-16
120
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will compare three versions of the Pericapsular Nerve Group (PENG) block in adults aged 65 years and older who are undergoing hip surgery. The PENG block is a regional anesthesia technique used to reduce pain around the hip joint and may improve early recovery after surgery. All patients in the study will receive the PENG block using 20 mL of 0.2% ropivacaine. They will then be randomly assigned to one of three groups: Group 1: PENG block using ropivacaine only (no additional medications). Group 2: PENG block using ropivacaine with 4 mg of dexamethasone injected near the nerves. Group 3: PENG block using ropivacaine with 25 micrograms of dexmedetomidine injected near the nerves. Dexamethasone and dexmedetomidine are medications that may increase the duration and quality of regional anesthesia. It is not known whether adding one of these medications provides longer-lasting or better pain relief compared to using ropivacaine alone. The main purpose of this study is to determine whether the addition of dexamethasone or dexmedetomidine improves the effectiveness of the PENG block in relieving pain after hip surgery. The study will evaluate pain levels, opioid consumption, time to first rescue pain medication, need for additional analgesia, and recovery outcomes. Safety, side effects, and any block-related complications will also be monitored. The investigators hypothesize that adding either perineural dexamethasone or dexmedetomidine will result in longer and more effective pain relief compared with the standard PENG block without an adjuvant. This research may help identify the most effective form of the PENG block for older adults undergoing hip surgery and contribute to improved pain management, reduced opioid use, and better postoperative recovery.
CONDITIONS
Official Title
Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 years or older
- Scheduled for elective or emergency hip surgery (e.g., hip fracture fixation or hip arthroplasty)
- ASA physical status I-III
- Planned use of a PENG block as part of perioperative analgesia
- Ability to communicate pain intensity using the NRS scale
- Written informed consent obtained from the patient or legal representative
You will not qualify if you...
- Refusal or inability to provide informed consent
- Known allergy, intolerance, or contraindication to ropivacaine, dexamethasone, or dexmedetomidine
- Pre-existing neurological deficit or neuropathy in the affected limb
- Coagulopathy or laboratory abnormalities contraindicating regional anesthesia (INR >1.5, platelet count <100,000/µL, or unsafe anticoagulation)
- Infection at or near the needle insertion site
- Severe liver or kidney impairment
- Chronic opioid therapy for more than 30 days before surgery
- Cognitive impairment or delirium preventing reliable pain assessment
- Body mass index over 40 kg/m²
- Previous regional block affecting the target area for current surgery
- Pregnancy or breastfeeding
- Participation in another interventional clinical trial within 30 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Poznan University of Medical Sciences
Poznan, Poland, 62-701
Actively Recruiting
Research Team
M
Malgorzata Reysner, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here